Open AccessImmunotherapy Extends Disease-Free Survival in Kidney Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000765104.93666.6f
Subject(s) - medicine , pembrolizumab , renal cell carcinoma , kidney cancer , nephrectomy , cancer , oncology , nivolumab , kidney disease , immunotherapy , surgery , kidney